FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2084634384> ?p ?o ?g. }

• W2084634384 endingPage "271" @default.
• W2084634384 startingPage "271" @default.
• W2084634384 abstract "This study was carried out to evaluate the efficacy and safety of doxercalciferol as therapy for secondary hyperparathyroidism (SHPT) in patients with chronic kidney disease (CKD) stage 4 in a prospective clinical trial. A total of 35 CKD-4 patients who had a baseline parathyroid hormone (iPTH) >150 pg/mL and had not received any vitamin D analog in the preceding 8 weeks were followed up at intervals of 6 weeks for 18 weeks on oral therapy with doxercalciferol. The starting dose was 1.5 μg/day, and the dose was increased in steps of 1 μg/day if iPTH did not decrease by at least 30% on the subsequent visit. Doxercalciferol was stopped temporarily if low iPTH (<70 pg/mL), hypercalcemia (>10.7 mg/dL), or severe hyperphosphatemia (>8.0 mg/dL) occurred, and was restarted at a lower dose on reversal of these abnormalities. Calcium acetate was the only phosphate binder used. Mean iPTH decreased by 35.4 ± 4.4% from 381.7 ± 31.3 pg/mL to 237.9 ± 25.7 pg/mL (<i>P</i> < 0.001). The proportion of patients who achieved 30% and 50% suppression of iPTH levels was 83% and 72%, respectively. Mean serum calcium, phosphorus, and calcium-phosphorus product values did not differ significantly from the baseline values. Four, two, and nine patients developed hypercalcemia, severe hyperphosphatemia, and high CaxP (>55), respectively. Almost all patients recovered to an acceptable level within 2 weeks of stopping doxercalciferol and adjusting the phosphate binder dose. In all, 21 patients required temporary stoppage of therapy. Most of them were restarted on therapy at a reduced dose during the study. It can, therefore, be concluded that doxercalciferol is effective in controlling SHPT in CKD-4 patients with an acceptable risk of hyperphosphatemia and hypercalcemia." @default.
• W2084634384 created "2016-06-24" @default.
• W2084634384 creator A5010273437 @default.
• W2084634384 creator A5036931186 @default.
• W2084634384 creator A5074250606 @default.
• W2084634384 creator A5081729501 @default.
• W2084634384 date "2013-01-01" @default.
• W2084634384 modified "2023-09-22" @default.
• W2084634384 title "Efficacy and safety of oral doxercalciferol in the management of secondary hyperparathyroidism in chronic kidney disease stage 4" @default.
• W2084634384 cites W1965298659 @default.
• W2084634384 cites W1983133134 @default.
• W2084634384 cites W1993858578 @default.
• W2084634384 cites W1999778136 @default.
• W2084634384 cites W2014420113 @default.
• W2084634384 cites W2018567109 @default.
• W2084634384 cites W2035171429 @default.
• W2084634384 cites W2039397162 @default.
• W2084634384 cites W2055923382 @default.
• W2084634384 cites W2073002613 @default.
• W2084634384 cites W2079498083 @default.
• W2084634384 cites W2136313468 @default.
• W2084634384 cites W2411016638 @default.
• W2084634384 cites W301308988 @default.
• W2084634384 doi "https://doi.org/10.4103/0971-4065.114492" @default.
• W2084634384 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3741971" @default.
• W2084634384 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23960343" @default.
• W2084634384 hasPublicationYear "2013" @default.
• W2084634384 type Work @default.
• W2084634384 sameAs 2084634384 @default.
• W2084634384 citedByCount "2" @default.
• W2084634384 countsByYear W20846343842016 @default.
• W2084634384 countsByYear W20846343842019 @default.
• W2084634384 crossrefType "journal-article" @default.
• W2084634384 hasAuthorship W2084634384A5010273437 @default.
• W2084634384 hasAuthorship W2084634384A5036931186 @default.
• W2084634384 hasAuthorship W2084634384A5074250606 @default.
• W2084634384 hasAuthorship W2084634384A5081729501 @default.
• W2084634384 hasBestOaLocation W20846343841 @default.
• W2084634384 hasConcept C124490489 @default.
• W2084634384 hasConcept C126322002 @default.
• W2084634384 hasConcept C126894567 @default.
• W2084634384 hasConcept C141071460 @default.
• W2084634384 hasConcept C146357865 @default.
• W2084634384 hasConcept C151730666 @default.
• W2084634384 hasConcept C2775945674 @default.
• W2084634384 hasConcept C2776036575 @default.
• W2084634384 hasConcept C2778653478 @default.
• W2084634384 hasConcept C2778838027 @default.
• W2084634384 hasConcept C2781208988 @default.
• W2084634384 hasConcept C519063684 @default.
• W2084634384 hasConcept C71924100 @default.
• W2084634384 hasConcept C86803240 @default.
• W2084634384 hasConcept C90924648 @default.
• W2084634384 hasConceptScore W2084634384C124490489 @default.
• W2084634384 hasConceptScore W2084634384C126322002 @default.
• W2084634384 hasConceptScore W2084634384C126894567 @default.
• W2084634384 hasConceptScore W2084634384C141071460 @default.
• W2084634384 hasConceptScore W2084634384C146357865 @default.
• W2084634384 hasConceptScore W2084634384C151730666 @default.
• W2084634384 hasConceptScore W2084634384C2775945674 @default.
• W2084634384 hasConceptScore W2084634384C2776036575 @default.
• W2084634384 hasConceptScore W2084634384C2778653478 @default.
• W2084634384 hasConceptScore W2084634384C2778838027 @default.
• W2084634384 hasConceptScore W2084634384C2781208988 @default.
• W2084634384 hasConceptScore W2084634384C519063684 @default.
• W2084634384 hasConceptScore W2084634384C71924100 @default.
• W2084634384 hasConceptScore W2084634384C86803240 @default.
• W2084634384 hasConceptScore W2084634384C90924648 @default.
• W2084634384 hasIssue "4" @default.
• W2084634384 hasLocation W20846343841 @default.
• W2084634384 hasLocation W20846343842 @default.
• W2084634384 hasLocation W20846343843 @default.
• W2084634384 hasLocation W20846343844 @default.
• W2084634384 hasOpenAccess W2084634384 @default.
• W2084634384 hasPrimaryLocation W20846343841 @default.
• W2084634384 hasRelatedWork W101943382 @default.
• W2084634384 hasRelatedWork W1511478437 @default.
• W2084634384 hasRelatedWork W1834773072 @default.
• W2084634384 hasRelatedWork W1860370092 @default.
• W2084634384 hasRelatedWork W1912199041 @default.
• W2084634384 hasRelatedWork W1986780781 @default.
• W2084634384 hasRelatedWork W2041692221 @default.
• W2084634384 hasRelatedWork W2143470199 @default.
• W2084634384 hasRelatedWork W2365762413 @default.
• W2084634384 hasRelatedWork W2370183213 @default.
• W2084634384 hasRelatedWork W2371762463 @default.
• W2084634384 hasRelatedWork W2391739660 @default.
• W2084634384 hasRelatedWork W2414539280 @default.
• W2084634384 hasRelatedWork W2526420455 @default.
• W2084634384 hasRelatedWork W2746036695 @default.
• W2084634384 hasRelatedWork W2772206284 @default.
• W2084634384 hasRelatedWork W2789453614 @default.
• W2084634384 hasRelatedWork W2906323197 @default.
• W2084634384 hasRelatedWork W849497366 @default.
• W2084634384 hasRelatedWork W2187792929 @default.
• W2084634384 hasVolume "23" @default.
• W2084634384 isParatext "false" @default.
• W2084634384 isRetracted "false" @default.

• next